REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma Care Ventures Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharma Care Ventures Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Pharma Care Ventures Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Shah Alam. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on March 26, 2014. The company’s latest financial report indicates a net sales revenue increase of 1.45% in 2022. Over the same period, its total assets grew by 3.37%. In 2022, Pharma Care Ventures Sdn. Bhd.’s net profit margin increased by 1.33%.

Headquarters
27-G, Jalan Tengku Ampuan Zabedah F9/F, Seksyen 9
Shah Alam; Selangor; Postal Code: 40100

Contact Details: Purchase the Pharma Care Ventures Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Pharma Care Ventures Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Pharma Care Ventures Sdn. Bhd. report to view the information.
Incorporation Date:
March 26, 2014
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Pharma Care Ventures Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
1.45%
Total operating revenue
1.45%
Operating profit (EBIT)
109.66%
EBITDA
87.23%
Net Profit (Loss) for the Period
109.66%
Total assets
3.37%
Total equity
42.77%
Operating Profit Margin (ROS)
1.33%
Net Profit Margin
1.33%
Return on Equity (ROE)
-54.33%
Debt to Equity Ratio
-3.75%
Quick Ratio
0.1%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?